The role of sodium valproate as an anti-manic agent

Seven manic patients fulfilling the diagnostic criteria of Feighner et al. who had not responded to previous treatment with lithium and neuroleptics were commenced on sodium valproate after their symptomatology had been rated on the In-patient Multidimensional Psychiatric Scale. Dosage was adjusted...

Ausführliche Beschreibung

Bibliographische Detailangaben
Veröffentlicht in:Interim guidelines for the control of infections with Vero cytotoxin producing Escherichia coli (VTEC). Subcommittee of the PHLS Working Group on Vero cytotoxin producing Escherichia coli (VTEC). - 1995. - 4(1984), 1 vom: 21., Seite 6-8
1. Verfasser: Prasad, A J (VerfasserIn)
Format: Aufsatz
Sprache:English
Veröffentlicht: 1984
Zugriff auf das übergeordnete Werk:Interim guidelines for the control of infections with Vero cytotoxin producing Escherichia coli (VTEC). Subcommittee of the PHLS Working Group on Vero cytotoxin producing Escherichia coli (VTEC)
Schlagworte:Journal Article Valproic Acid 614OI1Z5WI
Beschreibung
Zusammenfassung:Seven manic patients fulfilling the diagnostic criteria of Feighner et al. who had not responded to previous treatment with lithium and neuroleptics were commenced on sodium valproate after their symptomatology had been rated on the In-patient Multidimensional Psychiatric Scale. Dosage was adjusted up to a maximum of 1500 mg sodium valproate per day. After 6 weeks, 5 patients showed a definite clinical improvement which was further confirmed by the psychometric evaluation. The results suggest that the anticonvulsant drug sodium valproate may have anti-manic activity
Beschreibung:Date Completed 04.01.1985
Date Revised 21.11.2013
published: Print
Citation Status MEDLINE